Key result
mRNA analysis of the DMD gene identified genetic alterations in all 7 patients with Duchenne or Becker muscular dystrophy who remained undiagnosed after routine genetic testing.
Why the study?
Up to 7% of patients with DMD or BMD remain undiagnosed after routine genetic testing, likely due to undetected deep intronic variants, structural variants, or splicing alterations.
Does mRNA analysis improve genetic diagnosis in patients with clinically suspected DMD/BMD who remain undiagnosed after routine testing?
Observational (n=7)
Does mRNA analysis improve genetic diagnosis in patients with clinically suspected DMD/BMD who remain undiagnosed after routine testing?
mRNA analysis of the DMD gene from muscle biopsies can identify deep intronic variants and structural alterations in patients with DMD/BMD who remain undiagnosed by routine genetic testing.
May aid diagnosis in select undiagnosed DMD/BMD cases; leaves open routine adoption pending larger validation studies.
Background Up to 7% of patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) remain genetically undiagnosed after routine genetic testing. These patients are thought to carry deep intronic variants, structural variants or splicing alterations not detected through multiplex ligation-dependent probe amplification or exome sequencing. Methods RNA was extracted from seven muscle biopsy samples of patients with genetically undiagnosed DMD/BMD after routine genetic diagnosis. RT-PCR of the DMD gene was performed to detect the presence of alternative transcripts. Droplet digital PCR and whole-genome sequencing were also performed in some patients. Results We identified an alteration in the mRNA level in all the patients. We detected three pseudoexons in DMD caused by deep intronic variants, two of them not previously reported. We also identified a chromosomal rearrangement between Xp21.2 and 8p22. Furthermore, we detected three exon skipping events with unclear pathogenicity. Conclusion These findings indicate that mRNA analysis of the DMD gene is a valuable tool to reach a precise genetic diagnosis in patients with a clinical and anatomopathological suspicion of dystrophinopathy that remain genetically undiagnosed after routine genetic testing.
No takes yet. Share an insight, caveat, or question.
Segarra‐Casas et al. (2022) conducted an observational in Duchenne or Becker muscular dystrophy (n=7). mRNA analysis was evaluated on Alteration in the mRNA level. mRNA analysis of the DMD gene identified genetic alterations in all 7 patients with Duchenne or Becker muscular dystrophy who remained undiagnosed after routine genetic testing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: